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OBJECTIVES: 1. Dietary behavioural in an overweight and
obesity population in treatment, 2. Physical activity, 3. To eval-
uate if the group that reaches the minimum objective (weight loss
> 5%), has got more life style changes. METHODS: Randomised
controlled trial, 165-subjects: 70 control, 95 intervention.
Weight-reduced intervention, one year follow-up: low-calorie
diet, physical exercise promotion, behavioural modiﬁcation tech-
niques and health education. Variables: Sociodemography, nutri-
tion behaviour, physical activity, anthropometry (weight-loss
percentage, body mass index). Intention to treat analysis:
ANOVA, ji2; SPSS 11.0. RESULTS: Age 47.1 (SD12.1). In total,
82.4% Women, 53.9% very unsatisﬁed with the body image,
24.8% has never tried a weight-loss programme, 13.3% has tried
anoretic drugs. Meal Patterns: 93.3% eats at home, 65.9% in
family, 76.4% cooks herself, 65.2% eats only 2-times/day,
61.9% snacks and 54% eats binge, secret or night. Medium
meal-time: 20.1min (SD8.45). Their favourite foods: 37.6%
sweets, 21.8% animal fats, 11.5% bread or ﬂour foods, 5.5%
fruit and vegetables. Smoking 25.5%, drinks no alcohol 71.8%,
no exercise 61.2%. Homogeneity between control-intervention
groups: without signiﬁcant differences in age, sex, socioeconomic
characteristics and lifestyle behaviour. There are no differences
in weight measurements. Seventy-two subjects are lost (43.6%).
No signiﬁcant differences between the lost group and these who
complete the therapy in age, sex, previous pathology, habits or
weight. In the group that reaches the minimum objective, there
is declining of snacking, less appetence of bingeing, secret or
night eating, increasing of the daily meals and more time needed
in every meal (<0.05). Increasing physical exercise during and
post-treatment are associated with weight loss >5% (p < 0.05).
Higher intensity grade of physical activity during the diet is
related with leaving obesity (p = 0.00) and returning normal
weight (p < 0.001). People with successful outcome, experiment
increasing satisfaction with the body image (p = 0.00). CON-
CLUSIONS: 1. Nutrition behaviour in overweight and obese
patients are far away of the healthy lifestyle recommendations.
2. 61.2% no exercise. 3. The improvement in life style habits
produces a signiﬁcant weight loss >5%.
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OBJECTIVES: Prospective Obesity Cohort of Economic Evalu-
ation Determinants (PROCEED) is an ongoing longitudinal
cohort of overweight subjects aged 35–75 intending to lose
weight. The primary objective is to compare health care con-
sumptions and costs in subjects who are overweight (BMI 25
kg/m2) with or without abdominal obesity (AO) (waist circum-
ference 102cm for male and 88cm for female) versus non-over-
weight subjects (BMI 20–24kg/m2). METHODS: Recruitment
started in the US in November 2004. Internet-based follow-up
assessments will occur monthly for weight and waist circumfer-
ence of overweight subjects, and quarterly for health and eco-
nomic outcomes (hospitalizations, ER, outpatient services,
prescription medications for selected conditions) of all subjects.
RESULTS: Baseline analysis was conducted on non-overweight
subjects (100) and overweight subjects with waist circumference
measurement (293 without AO and 674 with AO). Health care
resource costs per participant were calculated by applying unit
costs to health care resource consumption reported at baseline
during the past 3 months. Mean costs in overweight subjects
with AO were almost twice those in overweight subjects without
AO ($132 versus $72), and over 3.5 times those of controls
($37). Overweight subjects with AO compared with those
without AO were more likely to have reported current prescrip-
tions for depression (21.1% versus 12.3%) and diabetes (11.9%
versus 4.4%). The percentage of subjects with zero costs was
23% and 31% in the overweight group (AO and non AO,
respectively) compared with 39% in the control group. CON-
CLUSION: Abdominal obesity appears to be associated with
markedly increase costs, especially those related to prescriptions.
As the PROCEED cohort progresses, further collection and
analyses of economic outcomes will allow a deeper understand-
ing of the impact of abdominal obesity on costs and health care
consumptions.
POB8
VALIDITY OF DATA COLLECTED FROM AN INTERNET-BASED
COHORT STUDY
Coste F1, Zhou X2, Radigue C1, Maneval F1
1Sanoﬁ-Synthelabo Research, Bagneux, Hauts-de-Seine, France; 2RTI
Health Solutions, Raleigh, NC, USA
OBJECTIVES: Assessment Towards Tobacco Economical and
Medical Prospective Trial (ATTEMPT) is a prospective multina-
tional observational longitudinal cohort designed to examine the
natural course of successive smoking cessation attempts and their
impact on health and economic outcomes. In order to evaluate
the validity of the data collected via the Internet, self-reported
weight and waist circumference (WC) were compared to in-home
assessed measurements. METHODS: Subjects were recruited
from existing Internet consumer panels Harris Interactive in 5
countries: Canada, France, Spain, the UK and the US. Subjects
had to be aged 35–65 years, smoke at least 5 cigarettes per day,
and intend to quit smoking. Assessments included questions 
on smoking status, health conditions, medical resource use and
quality of life. Study participants were mailed at home stan-
dardized weight scales and tape measures with instructions. In-
home assessments were performed by a health professional in a
random sample of the US subjects right after they completed the
quarterly Internet survey. RESULTS: Out of the 4647 subjects
included at baseline, 3242 (70%) completed the 3-month assess-
ments and 2917 (63%) completed the 6-month assessments. In
the US, 1147 (78%) subjects agreed to the in-home visit and 200
visits were conducted according to protocol speciﬁcations in
December 2004 and January 2005. No statistically signiﬁcant
difference and high positive correlations were found between
self-reported and observed weight (mean ± SD difference: under-
self-reported +0.6 ± 6.3kg; correlation: 0.95) and waist cir-
cumference (over-self-reported -0.3 ± 10.3cm; 0.81). The
distribution of demographic characteristics for the assessed
sample was similar to characteristics of the remaining cohort.
CONCLUSIONS: Based on good correlations between in-home
visit and self-reporting on the web in the US, Internet is a reli-
able tool to collect health related data. As the ATTEMPT cohort
progresses, this analysis will be reassessed with a greater sample
size and further explored in other countries.
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OBJECTIVE: A higher Body Mass Index (BMI) is associated
with decreased quality of life (QoL). Additional athropometric
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measurements like waist circumference (WC) may deﬁne obesity
and explain its health consequences. The objective of this study
was to determine if utility (EQ5Dindex) varied by BMI category,
as WC varied. METHODS: This retrospective study used the
latest data from the England Health Survey (2003). A general
linear model (GLM) was developed that included factors associ-
ated with utility, standardising for age and sex to generate esti-
mates of utility with relation to obesity (obesity categories:
normal [Nl, BMI 18.5–24.9kg/m2], overweight [Ov, 25.0–29.9
kg/m2], obese [Ob, ≥30kg/m2], and thirties of WC, L = low, M
= medium, and H = high). RESULTS: The standardised mean
utility by BMI category for men was: Nl = 0.877, Ov = 0.894,
Ob = 0.858. Standardised mean utility by BMI category for
women was: Nl = 0.879, Ov = 0.871, Ob = 0.812. Standardised
mean utility by WC category for men was: L = 0.887, M = 0.877,
H = 0.866. Standardised mean utility by WC category for women
was: L = 0.872, M = 0.857, H = 0.833. BMI and WC were depen-
dent and interacting determinants of utility. For females in the
nine obesity groups, the standardised mean utility was as
follows: Nl/L = 0.878, Nl/M = 0.877, Nl/H = 0.882, Ov/L =
0.896, Ov/M = 0.873, Ov/H = 0.844, Ob/L = 0.842, Ob/M =
0.822, Ob/H = 0.774. For men: Nl/L = 0.862, Nl/M = 0.882,
Nl/H = 0.888, Ov/L = 0.907, Ov/M = 0.893, Ov/H = 0.883,
Ob/L = 0.892, Ob/M = 0.856, Ob/H = 0.828. CONCLUSIONS:
In both women and men, the highest EQ5Dindex values (best QoL)
was evident in overweight people with a low WC. A reduction
in WC in obese people resulted in a greater gain in utility than
the same change in normal or overweight people. Use of both
BMI and WC, rather than a single measure of obesity, provided
a more precise prediction of health-related utility. Utility varied
more widely as a function of waist circumference in higher BMI
categories.
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Based on 31 concept-elicitation interviews of former smokers
and individuals who wanted to lose weight, a questionnaire was
developed simultaneously in three languages (French, US-English
and US-Spanish). Draft items were generated in each language
and culturally adapted into Spain-Spanish and UK-English. Face
validity was assessed through 30 cognitive debrieﬁng interviews;
resulting in a 27-item questionnaire. OBJECTIVE: To validate a
questionnaire that investigates the positive well-being associated
with behavioral changes in adults. METHODS: The psychome-
tric properties of the questionnaire were examined in US-English,
US-Spanish and French through a stand-alone study in former
smokers and individuals who wanted to lose weight. RESULTS:
Based on an initial Principal Component Analysis (PCA) and
item-item correlation analysis, 18 items were retained. A ﬁnal
PCA indicated that the questionnaire encompassed ﬁve dimen-
sions: Serenity; Healthy Lifestyle, Support from Others, Self-
Conﬁdence, and Social Life. The questionnaire surpassed the
threshold for internal consistency reliability for all dimensions
and globally (Cronbach’s alpha > 0.8) in both behavioral changes
and in all languages. All items surpassed the criterion for item-
convergent validity and item-discriminant validity was satisfac-
tory for 17/18 items. Correlations between the questionnaire and
the Psychological General Well-Being index (PGWBi) scores con-
ﬁrmed its validity and indicated that it supplements information
obtained through the PGWBi. Known-groups validity was satis-
factory in individuals who wanted to lose weight based on the
amount of weight lost, BMI reduction and number of weight loss
attempts, but was inconclusive in former smokers because the
abstinence status and the discontinuation of smoking cessation
aids were not conﬁrmed. CONCLUSION: Results support the
reliability and validity of this questionnaire making it a useful
tool for determining the positive well-being associated with
behavioral changes. The questionnaire is currently undergoing
additional validity testing in a population where smoking status
is assessed.
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OBJECTIVE: To analyze morbidity, mortality and the impact on
cost-effectiveness caused by the delay in having adequate arteri-
ovenous ﬁstulae (AVF) at start of periodic hemodialysis (PHD).
METHODS: Prospective study of 110 patients who started PHD
between January 1st 2002 and July 31 2004 with creatinine
clearance of 5–10mL/minute/1,73m_. Data: sociodemographic,
Charlson Comorbidity Index (CCI), type and duration of the
vascular access (VA), “de novo” morbidity and hospitalisations.
Patients were separated into three groups according to the VA at
start PHD (AVFgroup): Group 1(G1) having an adequate func-
tioning AVF before initiating HD; group 2(G2) not having an
AVF at the start of HD, but having it before three months; group
3(G3) using catheters during the ﬁrst three months. Patients who
had a delayed nephrology referral, those who suddenly started
PHD and those with Diabetes mellitus were excluded because
these are mortality risk factors. RESULTS: There were no sig-
niﬁcant differences between the three groups with respect to
initial variables of patients: age (p = 0.10), sex (p = 0.45), diag-
nostic of renal disease (p = 0.24) and CCI (p = 0.76). G1 patients
had lower “de novo” morbidity and less hospitalisations (p =
0.000). A logistic regression was applied with morbidity and hos-
pitalisations as dependent variables and age, sex, CCI and AVF-
group as co-variables: G2 and G3 were independently associated
with higher morbidity and hospitalisations (p < 0.01). Kaplan-
Meier analysis showed that G1 had better survival than G2 and
G3 (33 months vs. 27 and 24); and patients without morbidity
had better survival than those with. The Cox Regression (time
dependent model) analysis showed that not having an adequate
AVF at start of PHD (G2 and G3) reduced survival (RR:11.32;
CI:1.06–120.6). Cost-effectiveness analysis showed that G1
patients with respect to G2 and G3 had better survival and lower
cost per live gained month. CONCLUSIONS: “De novo” mor-
bidity caused by not having an adequate AVF at start of PHD
considerably decreases survival and implies higher cost.
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